AI Drug Discovery - Directory w/ AI Reviews

Drug discovery traditionally takes over a decade and billions of dollars — AI is compressing that timeline dramatically. AlphaFold's protein structure predictions have accelerated target identification across the pharmaceutical industry. Insilico Medicine and Exscientia use generative chemistry to design novel drug candidates, while Atomwise applies deep learning to molecular docking and Recursion runs biology experiments at robotic scale.

AlphaFold 1 4.9 New AlphaFold Free Free Plan API Open Source 3 reviews AlphaFold has transformed early-stage drug discovery by enabling researchers to predict the three-dimensional structures of target proteins with near-experimental accuracy. Pharmaceutical companies and academic labs use AlphaFold to identify binding sites, understand protein-ligand interactions, and Insilico Medicine 2 4.8 New Insilico Medicine Paid 2 reviews Insilico Medicine is a clinical-stage AI-driven drug discovery company that uses generative AI and deep learning across every stage of the pharmaceutical pipeline, from target identification to clinical trial design. The company's Pharma.AI platform encompasses three core modules: PandaOmics for tar Schrodinger 3 4.8 New Schrodinger Paid API 1 review Schrodinger is a leading computational chemistry and molecular simulation company whose physics-based AI platform is used to accelerate drug discovery and materials science research. The company's FEP+ (Free Energy Perturbation) technology uses molecular dynamics simulations enhanced with machine le Exscientia 4 4.8 New Exscientia Paid 2 reviews Exscientia combines AI drug design with precision medicine, advancing novel molecules into clinical trials. Atomwise 5 4.7 New Atomwise Paid 2 reviews Atomwise uses deep learning virtual screening to predict molecular binding to protein targets, screening billions of compounds to accelerate drug discovery. BenevolentAI 6 4.7 New BenevolentAI Paid 2 reviews BenevolentAI analyzes biomedical datasets with knowledge graphs and NLP to uncover novel drug targets, advancing programs into clinical trials. Recursion Pharmaceuticals 7 4.6 New Recursion Pharmaceuticals Paid 1 review Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines AI, automation, and high-throughput biology to industrialize drug discovery at scale. The company's platform generates one of the world's largest proprietary biological and chemical datasets through automated cell biol